A randomized phase II study of cilengitide (EMD 121974) in patients with metastatic melanoma.
Kim KB, Prieto V, Joseph RW, Diwan AH, Gallick GE, Papadopoulos NE, Bedikian AY, Camacho LH, Hwu P, Ng CS, Wei W, Johnson MM, Wittemer SM, Vardeleon A, Reckeweg A, Colevas AD.
Kim KB, et al. Among authors: vardeleon a.
Melanoma Res. 2012 Aug;22(4):294-301. doi: 10.1097/CMR.0b013e32835312e4.
Melanoma Res. 2012.
PMID: 22668797
Free PMC article.
Clinical Trial.